386 related articles for article (PubMed ID: 26097535)
1. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
[TBL] [Abstract][Full Text] [Related]
3. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF
Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723
[TBL] [Abstract][Full Text] [Related]
4. Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence.
Perez D; Herrmann T; Jungbluth AA; Samartzis P; Spagnoli G; Demartines N; Clavien PA; Marino S; Seifert B; Jaeger D
Int J Cancer; 2008 Oct; 123(7):1551-5. PubMed ID: 18646188
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
6. Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages.
Zang C; Zhao Y; Qin L; Liu G; Sun J; Li K; Zhao Y; Sheng S; Zhang H; He N; Zhao P; Wang Q; Li X; Peng Y; Dong T; Zhang Y
BMC Cancer; 2021 Sep; 21(1):1007. PubMed ID: 34496797
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.
Zhou JX; Li Y; Chen SX; Deng AM
J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023
[TBL] [Abstract][Full Text] [Related]
8. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.
Kim SH; Lee S; Lee CH; Lee MK; Kim YD; Shin DH; Choi KU; Kim JY; Park DY; Sol MY
Lung; 2009; 187(6):401-11. PubMed ID: 19795170
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
[TBL] [Abstract][Full Text] [Related]
11. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS
Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145
[TBL] [Abstract][Full Text] [Related]
13. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
14. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
15. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
16. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
Riener MO; Wild PJ; Soll C; Knuth A; Jin B; Jungbluth A; Hellerbrand C; Clavien PA; Moch H; Jochum W
Int J Cancer; 2009 Jan; 124(2):352-7. PubMed ID: 18942708
[TBL] [Abstract][Full Text] [Related]
17. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
Sharma P; Shen Y; Wen S; Bajorin DF; Reuter VE; Old LJ; Jungbluth AA
Clin Cancer Res; 2006 Sep; 12(18):5442-7. PubMed ID: 17000678
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.
Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S
Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246
[TBL] [Abstract][Full Text] [Related]
19. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
[TBL] [Abstract][Full Text] [Related]
20. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
Sideras K; Bots SJ; Biermann K; Sprengers D; Polak WG; IJzermans JN; de Man RA; Pan Q; Sleijfer S; Bruno MJ; Kwekkeboom J
Br J Cancer; 2015 Jun; 112(12):1911-20. PubMed ID: 26057582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
